---
title: Boosting pharmaceutical research with microbiome data
description: Microbiome-based evidence is set to drive understanding of how drugs interact with human ‘host’ environments, helping devise more targeted treatments and create business opportunities, reports Anthony Finbow, CEO of Eagle Genomics.
image: https://www.eaglegenomics.com/hubfs/EagleGenomics_PressCoverage_2021-01-18_BoostingPharmaMicrobiome.png
---

- [Home](https://www.eaglegenomics.com)
- What We Do 
    - [e\[datascientist\]](https://www.eaglegenomics.com/what-we-do/e-datascientist-platform) 
          - [e\[exploration\]](https://www.eaglegenomics.com/what-we-do/e-datascientist-platform/e-exploration)
          - [e\[biology\]](https://www.eaglegenomics.com/what-we-do/e-datascientist-platform/e-biology)
          - [e\[datascience\]](https://www.eaglegenomics.com/what-we-do/e-datascientist-platform/e-data-science)
          - [e\[sdk\]](https://www.eaglegenomics.com/what-we-do/e-datascientist-platform/e-software-development-kit)
          - [e\[marketplace\]](https://www.eaglegenomics.com/what-we-do/e-datascientist-platform/e-marketplace)
    - [Microbial Strain Characterization](https://www.eaglegenomics.com/microbial-strain-characterisation)
    - [Networking Microbiome Science](https://www.eaglegenomics.com/what-we-do/networking-microbiome-science)
- [About Us](https://www.eaglegenomics.com/about-us)
- [Customers](https://www.eaglegenomics.com/customers)
- [News](https://www.eaglegenomics.com/news)
- [Contact Us](https://www.eaglegenomics.com/contact-us)

[Skip to content](https://www.eaglegenomics.com/news/boosting-pharmaceutical-research-with-microbiome-data#main-content)

[![EG-01](https://www.eaglegenomics.com/hubfs/EG-01.svg "EG-01")](https://www.eaglegenomics.com/)

[Get in touch](https://www.eaglegenomics.com/contact-us)

- [Home](https://www.eaglegenomics.com/?hsLang=en)
- [News](https://www.eaglegenomics.com/news)
- Press Coverage

Jan 18, 2021 4:30:00 PM

# Boosting pharmaceutical research with microbiome data

  

## Boosting pharmaceutical research with microbiome data

Microbiome-based evidence is set to drive understanding of how drugs interact with human ‘host’ environments, helping devise more targeted treatments and create business opportunities, reports **Anthony Finbow,** CEO of Eagle Genomics.

[![Read the article](https://no-cache.hubspot.com/cta/default/2869527/fd01152b-a63b-4607-9339-f53b687b62dd.png)](https://cta-redirect.hubspot.com/cta/redirect/2869527/fd01152b-a63b-4607-9339-f53b687b62dd) 

 Go Back

---

 Share: <https://www.facebook.com/sharer/sharer.php?u=https://www.eaglegenomics.com/news/boosting-pharmaceutical-research-with-microbiome-data> <http://twitter.com/share?text=Eagle%20Genomics:%20Boosting%20pharmaceutical%20research%20with%20microbiome%20data&url=https://www.eaglegenomics.com/news/boosting-pharmaceutical-research-with-microbiome-data> <https://www.linkedin.com/sharing/share-offsite/?url=https://www.eaglegenomics.com/news/boosting-pharmaceutical-research-with-microbiome-data>

[datasets](https://www.eaglegenomics.com/news/tag/datasets), [Eagle Genomics](https://www.eaglegenomics.com/news/tag/eagle-genomics), [microbiome](https://www.eaglegenomics.com/news/tag/microbiome), [data science](https://www.eaglegenomics.com/news/tag/data-science), [biopharma](https://www.eaglegenomics.com/news/tag/biopharma)

### [™](https://www.eaglegenomics.com/what-we-do/e-datascientist-platform)

- [Applications](https://www.eaglegenomics.com/what-we-do/e-datascientist-platform)
- [Networking Microbiome Science](https://www.eaglegenomics.com/what-we-do/networking-microbiome-science)

### Quick Links

- [About Us](https://www.eaglegenomics.com/about-us)
- [Success Stories](https://www.eaglegenomics.com/success-stories)
- [News & Blog](https://www.eaglegenomics.com/news)
- [Knowledge Hub](https://www.eaglegenomics.com/knowledge-hub)

### Contact Details

[contact@eaglegenomics.com](mailto:contact@eaglegenomics.com) 

[Get in touch](https://www.eaglegenomics.com/contact-us)

- [Privacy Statement](https://www.eaglegenomics.com/privacy-statement)
- [Terms & Conditions](https://www.eaglegenomics.com/terms-conditions)

© 2023 All rights reserved

[Follow us on LinkedIn](https://www.linkedin.com/company/eagle-genomics-ltd-/) [Follow us on Twitter](https://twitter.com/eaglegen) [Follow us on Facebook](https://en-gb.facebook.com/eaglegenomics/)

[Get in touch](https://www.eaglegenomics.com/contact-us#get-in-touch)

```json
{
  "@context" : "http://schema.org",
  "@type" : "Article",
  "author" : {
    "@type" : "Organization",
    "Sameas" : "https://www.eaglegenomics.com/",
    "logo" : {
      "@type" : "ImageObject",
      "url" : "https://www.eaglegenomics.com/hubfs/EG-01.svg"
    },
    "name" : "Eagle Genomics"
  },
  "datePublished" : "date",
  "description" : "Microbiome-based evidence is set to drive understanding of how drugs interact with human &lsquo;host&rsquo; environments, helping devise more targeted treatments and create business opportunities, reports Anthony Finbow, CEO of Eagle Genomics.",
  "headline" : "Boosting pharmaceutical research with microbiome data",
  "image" : {
    "@type" : "ImageObject",
    "url" : "https://2869527.fs1.hubspotusercontent-na1.net/hubfs/2869527/EagleGenomics_PressCoverage_2021-01-18_BoostingPharmaMicrobiome.png"
  },
  "mainEntityOfPage" : {
    "@type" : "WebPage"
  },
  "publisher" : {
    "@type" : "Organization",
    "Sameas" : "https://www.eaglegenomics.com/",
    "logo" : {
      "@type" : "ImageObject",
      "url" : "https://www.eaglegenomics.com/hubfs/EG-01.svg"
    },
    "name" : "Eagle Genomics"
  }
}
```

```json
{
  "@context" : "https://schema.org",
  "@id" : "https://www.eaglegenomics.com/#BreadCrumbList",
  "@type" : "BreadcrumbList",
  "itemListElement" : [ {
    "@type" : "ListItem",
    "item" : "https://www.eaglegenomics.com/",
    "name" : "Home",
    "position" : 1
  }, {
    "@type" : "ListItem",
    "item" : "https://www.eaglegenomics.com/success-stories",
    "name" : "Success Stories",
    "position" : 2
  }, {
    "@type" : "ListItem",
    "item" : "https://www.eaglegenomics.com/news/boosting-pharmaceutical-research-with-microbiome-data",
    "name" : "Press Coverage",
    "position" : 3
  } ]
}
```